SpecCheck vs Abridge

Side-by-side comparison of AI visibility scores, market position, and capabilities

Abridge leads in AI visibility (41 vs 20)
SpecCheck logo

SpecCheck

EmergingHealthcare

General

SF optical industry B2B platform unifying eyewear ordering, tracking, and billing for eye care professionals; YC W23 $3.82M Initialized Capital seed targeting $68.3B US optical market fragmented across doctors, labs, and insurers.

AI VisibilityBeta
Overall Score
D20
Category Rank
#395 of 1158
AI Consensus
75%
Trend
up
Per Platform
ChatGPT
28
Perplexity
31
Gemini
20

About

SpecCheck is a San Francisco-based optical industry B2B platform — backed by Y Combinator (W23) with $3.82 million raised including a $3.7 million seed round led by Initialized Capital in October 2023 — providing eye care professionals and optical businesses with a unified prescription eyewear ordering, tracking, and billing system that connects optometrists, opticians, and optical labs in a single workflow to eliminate the manual coordination, phone calls, and paper-based processes that dominate the $68.3 billion US optical industry. Founded in 2023, SpecCheck addresses the fragmentation in optical dispensing workflow where prescriptions travel between eye doctors, dispensing opticians, and fulfillment labs through a mix of fax, phone, and disconnected software systems.

Full profile
Abridge logo

Abridge

EmergingHealthcare

General

Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.

AI VisibilityBeta
Overall Score
C41
Category Rank
#777 of 1158
AI Consensus
50%
Trend
up
Per Platform
ChatGPT
35
Perplexity
49
Gemini
33

About

Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.

Full profile

AI Visibility Head-to-Head

20
Overall Score
41
#395
Category Rank
#777
75
AI Consensus
50
up
Trend
up
28
ChatGPT
35
31
Perplexity
49
20
Gemini
33
26
Claude
51
28
Grok
38

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.